Stock Taper
ELV
ELEVANCE HEALTH INC.
NYSE
$403.93
▲ UP 0.22% (0.89)

KEY STATISTICS

Market Cap$87.40 B
52w High$436.24
52w Low$274.84
Dividend Yield1.84%
FrequencyQuarterly
P/E13.74
Volume72.45K
Shares Out.216.87M

COMPANY

LEADERSHIP

Gail Koziara Boudreaux
CHIEF EXECUTIVE
Gail Koziara Boudreaux

COMPENSATION 2026

Salary$555,667
Stock Awards$792,000
Incentive Plan Pay$0
All Other Comp.$125,953
Total$2,440,530

ABOUT

SECTOR
Healthcare
WENT PUBLIC
October 30, 2001
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
96,615

PRICE TARGET

Target High$498.00
Target Low$391.00
Target Median$456.00
Target Consensus$444.06

UPCOMING EARNINGS

DateOct 21, 2026
DayWednesday
Rev. Est.$49.30B
OCT
21
WED

SPLIT RECORD

DATETYPERATIO
2005-06-01Forward2:1

PRICE

$403.93 ▲ UP 0.22% (+$0.89)
OVERLAYS
$404$406$4089:30 AM9:39 AM9:48 AM9:57 AM10:06 AM10:15 AM10:24 AM403.93

About Elevance Health Inc.

https://www.elevancehealth.com ↗

Elevance Health Inc., formerly Anthem, Inc., is a health benefits company serving 118 million people with medical, digital, pharmacy, behavioral, and care solutions to support healthier lives nationwide.

INDUSTRY

Medical - Healthcare Plans

A SERVICE ELEVANCE HEALTH INC. IS KNOWN FOR

Health Insurance Plans

Elevance Health provides diverse health insurance plans, including HMOs, PPOs, Medicare, and Medicaid, through affiliates like Anthem Blue Cross and Blue Shield, serving over 47 million members with medical, pharmaceutical, dental, and behavioral ...

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Health Benefits Segment$42.25B $41.84B $42.49B $42.72B
Carelon Services Segment$18.32B $18.66B $17.96B $19.23B
Segment Eliminations-$10.96B -$12.13B

RATINGS SNAPSHOT

Overall rating: B+

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity4
Return On Assets4
Debt To Equity1
Price To Earnings2
Price To Book3
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Ro Khanna
Ro Khanna
Sale
2026-01-29
SENATE TRADES
Markwayne Mullin
Markwayne Mullin
Purchase
2025-12-29
John Fetterman
John Fetterman
Sale
2025-09-19
HOUSE TRADES
Lisa McClain
Lisa McClain
Sale
2025-08-13

INSIDER TRADES

DIRECTOR, OFFICER: PRESIDENT AND CEO
BOUDREAUX GAIL
Purchase · 2.0K shares
2026-07-17
DIRECTOR, OFFICER: PRESIDENT AND CEO
BOUDREAUX GAIL
Purchase · 680 shares
2026-07-17
DIRECTOR
PERU RAMIRO G
Purchase · 1.0K shares
2026-07-17
OFFICER: CAO & CONTROLLER
Penczek Ronald W
Sale · 369 shares
2026-06-12

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 7
OVERWEIGHT 4
OUTPERFORM 3
MARKET PERFORM 1
NEUTRAL 1
SECTOR PERFORM 1
EQUAL WEIGHT 1
IN LINE 1
19 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
CVS$96.77COMPARE
GSK$50.58COMPARE
REGN$821.70COMPARE
CI$281.03COMPARE
COR$329.03COMPARE
BDX$187.61COMPARE
HUM$390.93COMPARE
IDXX$545.47COMPARE